Rv2681 - c.390A>C
Drug resistance types
0 Sensitive
1 RR-TB
11 HR-TB
0 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
11 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage2.1;lineage4.9;lineage6.3 | 4 |
| La1.7;lineage4.9 | 2 |
| lineage2.1 | 1 |
| La3;lineage4.9 | 1 |
| La3;lineage2.1;lineage6.3 | 1 |
| M.canetti;lineage2.1;lineage2.2.1;lineage4.9;lineage6.3 | 1 |
| lineage4.9;lineage6.3 | 3 |
| lineage2.2.1;lineage6.3 | 1 |
| lineage2.2.1 | 1 |
| lineage4.9 | 4 |
| La3;lineage2.1;lineage4.9;lineage6.3 | 2 |
| 1 | |
| M.canetti;lineage2.1;lineage4.9 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 23 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR3675490 | Other | lineage2.1;lineage4.9;lineage6.3 | None | ERR176560 | HR-TB | La1.7;lineage4.9 | None | SRR12142341 | HR-TB | lineage2.1 | None | ERR212034 | HR-TB | La1.7;lineage4.9 | None | ERR181744 | HR-TB | La3;lineage4.9 | None | ERR4810741 | HR-TB | La3;lineage2.1;lineage6.3 | None | SRR3742665 | HR-TB | M.canetti;lineage2.1;lineage2.2.1;lineage4.9;lineage6.3 | None | SRR28119717 | Other | lineage4.9;lineage6.3 | None | SRR28119811 | Other | lineage2.2.1;lineage6.3 | None | SRR6458423 | HR-TB | lineage2.2.1 | None | ERR13265748 | Other | lineage4.9;lineage6.3 | None | ERR3283018 | HR-TB | lineage4.9 | None | SRR28119805 | Other | lineage4.9 | None | SRR8552928 | HR-TB | lineage2.1;lineage4.9;lineage6.3 | None | SRR28119756 | Other | lineage4.9;lineage6.3 | None | ERR4811142 | RR-TB | La3;lineage2.1;lineage4.9;lineage6.3 | None | ERR4811105 | HR-TB | La3;lineage2.1;lineage4.9;lineage6.3 | None | SRR3675236 | Other | None | ERR3283042 | Other | lineage4.9 | None | ERR4811075 | Other | lineage2.1;lineage4.9;lineage6.3 | None | ERR4811022 | HR-TB | M.canetti;lineage2.1;lineage4.9 | None | ERR161037 | Other | lineage4.9 | None | ERR4811311 | Other | lineage2.1;lineage4.9;lineage6.3 | None |
|---|
